The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124070462 12407046 2 F 20160318 20160831 20160526 20160902 EXP JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-025279 BRISTOL MYERS SQUIBB 85.44 YR M Y 0.00000 20160902 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124070462 12407046 1 PS ELIQUIS APIXABAN 1 Oral 10 MG, BID 60 MG Y 202155 10 MG FILM-COATED TABLET BID
124070462 12407046 2 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral 75 MG, QD Y 0 75 MG TABLET QD
124070462 12407046 3 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral 75 MG, QD Y 0 75 MG TABLET QD
124070462 12407046 4 C AMLODIN AMLODIPINE BESYLATE 1 Oral 5 MG, QD 0 5 MG TABLET QD
124070462 12407046 5 C FRANDOL ISOSORBIDE DINITRATE 1 Transdermal 40 MG, QD 0 40 MG QD
124070462 12407046 6 C TENELIA TENELIGLIPTIN 1 Oral 20 MG, QD 0 20 MG TABLET QD
124070462 12407046 7 C MUCOSTA REBAMIPIDE 1 Oral 100 MG, TID 0 100 MG TABLET TID
124070462 12407046 8 C SENNOSIDE /00571901/ SENNOSIDES A AND B 1 Oral 12 MG, PRN 0 12 MG TABLET
124070462 12407046 9 C LONASEN BLONANSERIN 1 Oral 8 MG, BID 0 8 MG TABLET BID
124070462 12407046 10 C ZOPICLONE ZOPICLONE 1 Oral 7.5 MG, QD 0 7.5 MG TABLET QD
124070462 12407046 11 C AMBROXOL HYDROCHLORIDE AMBROXOL HYDROCHLORIDE 1 Oral 15 MG, TID 0 15 MG TABLET TID
124070462 12407046 12 C ERYTHROCIN /00020901/ ERYTHROMYCIN ETHYLSUCCINATE 1 Oral 200 MG, BID 0 200 MG TABLET BID
124070462 12407046 13 C URIEF SILODOSIN 1 Oral 4 MG, BID 0 4 MG TABLET BID
124070462 12407046 14 C PROSTAL /00093602/ 2 Oral 25 MG, BID 0 25 MG TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124070462 12407046 1 Thrombosis prophylaxis
124070462 12407046 2 Myocardial ischaemia
124070462 12407046 3 Antiplatelet therapy
124070462 12407046 4 Hypertension
124070462 12407046 5 Myocardial ischaemia
124070462 12407046 6 Diabetes mellitus
124070462 12407046 7 Gastric disorder
124070462 12407046 8 Constipation
124070462 12407046 9 Psychotic disorder
124070462 12407046 10 Psychotherapy
124070462 12407046 11 Productive cough
124070462 12407046 12 Antibiotic therapy
124070462 12407046 13 Micturition disorder
124070462 12407046 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
124070462 12407046 OT
124070462 12407046 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
124070462 12407046 Asphyxia
124070462 12407046 Contraindicated product administered
124070462 12407046 Melaena
124070462 12407046 Oedema peripheral

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124070462 12407046 1 20160316 20160318 0
124070462 12407046 2 20160318 0
124070462 12407046 3 20160325 0
124070462 12407046 5 20140606 0